Health symptoms you shouldn't ignore (Calgary Sun)
When should you worry about symptoms? After all, we all have an occasional ache and pain, indigestion, diarrhea, constipation, visual troubles and shortness of breath.
Sucampo Initiates Phase 1 Study Of SPL-017 For Peripheral Arterial Disease (Medical News Today)
Sucampo Pharma, Ltd., of Japan, a wholly-owned subsidiary of Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP), today announced that it has initiated dosing in a first-in-human clinical safety study of a proprietary prostone, SPL-017, as a potential treatment for peripheral arterial disease (PAD).
Pluristem Therapeutics Inc. Announces Filing An IMPD To Commence Clinical Trials Utilizing PLX-PAD For Critical Limb ... (Medical News Today)
Pluristem Therapeutics Inc.
Sucampo Initiates Phase 1 Study of SPL-017 for Peripheral Arterial ... - MarketWatch In extreme cases, PAD can lead to critical ischemic lesion and eventually to loss of a leg by amputation. Gayle Dolecek, PD, Senior Vice President, ...
Pluristem Therapeutics Inc. Announces Filing an IMPD to Commence ... - WELT ONLINE The Company's products in development also include PLX-IBD, targeting Inflammatory Bowel Disease (IBD); PLX-MS, targeting Multiple Sclerosis; PLX-BMT, ...
Flickr pictures related to ischemic bowel disease
No comments:
Post a Comment